Feline Respiratory Infections: Etiology, Transmission, Zoonotic Risk, and Clinical Management

Introduction

Feline respiratory infections represent a complex of contagious diseases affecting the upper and lower respiratory tracts of domestic cats. These infections are caused by a diverse array of pathogens, including viruses, bacteria, fungi, and parasites [1, 2]. Among the most clinically significant agents are feline herpesvirus-1 (FHV-1), feline calicivirus (FCV), Bordetella bronchiseptica, and Chlamydia felis [3, 2]. Understanding the etiology, transmission pathways, zoonotic potential, and clinical management of these infections is essential for veterinary practitioners, diagnostic laboratories, and public health professionals.

Etiology: Viral and Bacterial Pathogens

Viral Agents

Feline herpesvirus-1 (FHV-1) is an enveloped, double-stranded DNA virus belonging to the family Herpesviridae. The virus establishes lifelong latency in trigeminal ganglia after primary infection, with reactivation occurring during stress or immunosuppression [4]. FHV-1 exploits lipid rafts on permissive cell membranes during entry, a process that represents a potential target for antiviral intervention [4]. Feline calicivirus (FCV) is a non-enveloped, single-stranded positive-sense RNA virus in the family Caliciviridae [5, 6]. FCV exhibits high genetic diversity and can cause both classical upper respiratory disease and severe systemic virulent forms characterized by edema and pneumonia [6]. Reverse genetics systems have been developed to study FCV replication and host proteomic responses [5]. Additionally, gammaherpesviruses have been detected in cats with and without upper respiratory tract disease, though their pathogenic role remains under investigation [7]. Feline circovirus-1 and feline chaphamaparvovirus have also been identified in respiratory disease contexts, suggesting a broader viral landscape [8, 9]. Highly pathogenic avian influenza A(H5N1) has emerged as a significant feline respiratory pathogen in Europe, with confirmed infections in domestic cats linked to poultry contact [10, 11, 12, 13].

Bacterial Agents

Primary bacterial pathogens of the feline respiratory tract include Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma species. B. bronchiseptica is a Gram-negative coccobacillus that colonizes the ciliated respiratory epithelium and is associated with kennel cough in dogs and respiratory disease in cats [14, 1]. C. felis is an obligate intracellular bacterium that primarily causes conjunctivitis but also contributes to upper respiratory signs [3]. Prevalence studies have identified risk factors including multi-cat housing and young age [3]. Mycoplasma felis and Mycoplasma cynos are cell-wall-deficient bacteria that can cause conjunctivitis and pneumonia; genomic analyses have characterized their antimicrobial resistance determinants and virulence factors [15, 16]. Mycoplasma cynos in particular has been associated with lower respiratory tract disease in cats [16].

Other notable bacterial causes include Klebsiella pneumoniae, which has been isolated from respiratory-diseased pet cats with demonstrable antimicrobial resistance patterns [17]. Opportunistic infections by Nocardia farcinica, Rickettsia felis, Mycobacterium bovis, and Mycobacterium orygis have been reported, the latter two representing significant zoonotic concerns [18, 19, 20, 21]. Emerging zoonotic mycobacteria, such as M. orygis, have been identified in fatal feline pulmonary tuberculosis cases [21]. Fungal agents such as Cryptococcus species and parasitic agents including Aelurostrongylus abstrusus also contribute to feline respiratory disease [22, 23, 24, 25].

Coinfections

Coinfections are common in feline upper respiratory tract disease. Studies have reported high rates of concurrent viral and bacterial detection, with FHV-1 and FCV frequently co-occurring with C. felis, B. bronchiseptica, and Mycoplasma species [1, 2]. The presence of multiple pathogens can exacerbate clinical severity and complicate diagnostic interpretation [1].

Transmission Pathways

How do cats get respiratory infections? Transmission occurs primarily through direct contact with infected individuals via aerosolized respiratory secretions, fomites, and contaminated environments [1, 2]. FHV-1 is shed in ocular, nasal, and oral secretions, with latent carriers serving as a persistent source of infection during reactivation [4]. FCV is shed in saliva, ocular discharge, and feces, and can survive on fomites for extended periods due to its non-enveloped structure [26, 27]. B. bronchiseptica is transmitted through direct contact and aerosolization, with shedding persisting for weeks after clinical recovery [14]. C. felis is primarily transmitted via direct contact with infected ocular and nasal discharges [3].

Multi-cat environments such as shelters, catteries, and boarding facilities facilitate rapid spread. Young age, stress, poor ventilation, and overcrowding increase transmission risk [1]. A recent epidemiological study during the COVID-19 pandemic identified that reduced human movement altered pathogen circulation patterns in cat populations [1].

Clinical Signs and Pathophysiology

Are cat respiratory infections dangerous? Clinical severity ranges from mild conjunctivitis to severe pneumonia and death. Common clinical signs include sneezing, nasal discharge, ocular discharge, conjunctivitis, corneal ulceration (especially with FHV-1), oral ulceration (classically with FCV), pyrexia, lethargy, and inappetence [28, 2]. FHV-1 infection often presents with serous to mucopurulent nasal discharge, and severe cases may lead to chronic rhinosinusitis [4]. FCV may cause limping syndrome and virulent systemic disease with footpad edema and fatal pneumonia [6]. Lower respiratory tract involvement manifests as cough, tachypnea, dyspnea, and abnormal lung sounds. Bacterial pneumonia can result from primary pathogens or secondary invasion [29]. B. bronchiseptica can cause bronchopneumonia, particularly in kittens [14]. Pulmonary nematodes such as A. abstrusus induce granulomatous inflammation, with radiographic and ultrasonographic findings aiding diagnosis [23, 25]. Acute phase protein responses, including serum amyloid A and haptoglobin, are elevated in cats with respiratory disease and may serve as biomarkers of inflammation [30].

Ophthalmic manifestations are common, especially with FHV-1 and C. felis, and include keratitis, conjunctivitis, and corneal sequestra in chronic cases [28]. Prompt management of ocular signs is critical to prevent permanent vision impairment [28].

Zoonotic Risk

Is cat respiratory infection contagious to humans? The zoonotic potential of feline respiratory pathogens varies by agent. B. bronchiseptica can infect immunocompromised humans, causing respiratory disease, although transmission from cats to humans is rare [14]. C. felis has been reported to cause conjunctivitis in humans, primarily through direct contact with infected ocular secretions [3]. Mycobacterium bovis and M. orygis are established zoonotic pathogens; cats can serve as sentinels or sources of infection for humans through respiratory secretions or bite wounds [20, 21]. Rickettsia felis is an emerging zoonotic pathogen associated with flea vectors, and pneumonia caused by R. felis has been diagnosed in humans using molecular techniques [18]. Highly pathogenic avian influenza A(H5N1) infection in cats raises pandemic concerns due to the potential for mammalian adaptation and spillover to humans, particularly among veterinary personnel and first responders exposed to infected animals [10, 11, 12, 13]. Cryptococcus species, while primarily an environmental fungus, can infect humans through inhalation of aerosolized yeast from feline lesions [22].

Overall, the risk of zoonotic transmission from feline respiratory infections is considered low for immunocompetent individuals, but immunocompromised persons should exercise caution. Standard hygiene practices, including hand washing and use of personal protective equipment when handling sick cats, reduce transmission risk.

Diagnostic Approaches

Diagnosis of feline respiratory infections relies on a combination of clinical evaluation, molecular diagnostics, serology, and imaging. Rapid and specific pathogen identification is crucial for targeted therapy and infection control.

Molecular Diagnostics

Nucleic acid amplification tests, particularly polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP), are the gold standard for detecting FHV-1, FCV, C. felis, B. bronchiseptica, and Mycoplasma species from conjunctival, nasal, or oropharyngeal swabs [31]. Portable microfluidic LAMP platforms have been developed for multiplex detection of multiple feline respiratory pathogens, offering point-of-care capabilities [31]. Immunochromatographic test strips using fluorescent microspheres enable rapid FHV-1 antigen detection [32]. Targeted next-generation sequencing (tNGS) of bronchoalveolar lavage fluid has been used to identify rare pathogens such as R. felis [18]. Reverse transcription PCR is essential for detecting RNA viruses such as FCV and influenza A virus [26, 5, 12].

Serology and Cytology

Serological assays, including commercial ELISA kits, can detect antibodies against FHV-1, FCV, and C. felis, but are less useful for acute diagnosis due to the prevalence of vaccination-induced antibodies. Cytological examination of nasal exudate or bronchoalveolar lavage may reveal intracellular bacteria (e.g., C. felis inclusions), fungal elements, or eosinophilic inflammation suggestive of parasitic infection. Acute phase protein measurement adds supportive information [30].

Imaging

Thoracic radiography and point-of-care ultrasound are valuable for assessing lower respiratory tract involvement, including pneumonia, lung masses, and pleural effusion [25]. Ultrasonographic findings in parasitic pneumonia may include subpleural nodules and consolidations [25].

Diagnostic Decision Tree

The following Mermaid diagram outlines a structured diagnostic approach for feline respiratory infections:

flowchart TD
    A[Cat with respiratory signs], > B{Clinical examination}
    B, > C[Ocular/nasal discharge, sneezing, cough]
    C, > D[Collect conjunctival, nasal, or oropharyngeal swab]
    D, > E[Perform multiplex PCR/LAMP for FHV-1, FCV, C. felis, B. bronchiseptica, Mycoplasma spp.]
    E, > F{Pathogen detected?}
    F, >|Yes| G[Targeted antiviral or antibiotic therapy]
    F, >|No| H[Consider additional testing]
    H, > I[tNGS/BALF for unusual pathogens]
    H, > J[Thoracic imaging for lower respiratory disease]
    H, > K[Serology for fungal or parasitic agents]
    G, > L[Monitor clinical response]
    I, > L
    J, > L
    K, > L

Clinical Management

Antiviral Therapy

Antiviral options for FHV-1 include famciclovir, which is administered orally and reduces viral shedding and clinical severity [4]. Investigational compounds targeting lipid raft-mediated entry show promise [4]. For FCV, nucleoside analogues and the dihydroorotate dehydrogenase inhibitor lapachol have demonstrated antiviral activity both in vitro and in vivo [27]. An engineered mRNA vaccine targeting the FCV VP1 protein has shown complete protection in experimental challenges [26].

Antibacterial Therapy

Empirical antibiotic therapy for bacterial components should cover B. bronchiseptica, C. felis, and Mycoplasma species. Doxycycline remains the first-line agent for C. felis and Mycoplasma infections [3, 16]. B. bronchiseptica is often susceptible to tetracyclines and fluoroquinolones, but antimicrobial susceptibility testing is recommended due to emerging resistance [14, 16]. A systematic review and meta-analysis comparing short versus long antibiotic courses for pneumonia in cats found that shorter durations (5-7 days) may be non-inferior to longer courses (10-14 days) in uncomplicated cases, with reduced risk of antimicrobial resistance [29]. For mycobacterial infections, multi-drug regimens with rifampicin, macrolides, and fluoroquinolones are required, but outcomes are guarded [20, 21].

Supportive Care

Supportive care is the cornerstone of management and includes nutritional support, fluid therapy, humidification, and nasal clearance. Ophthalmic care with topical lubricants and antiviral agents is critical [28]. Severe cases may require hospitalization, oxygen therapy, and nebulization.

Vaccination

Core vaccines against FHV-1 and FCV are widely available and reduce disease severity but do not prevent infection or shedding entirely [26, 5]. An mRNA vaccine for FCV and an inactivated B. bronchiseptica vaccine have shown efficacy in clinical trials [14, 26]. Vaccination against C. felis is also available in some regions. Annual booster protocols are recommended for at-risk populations.

Biosecurity and Prevention

Preventing transmission relies on reducing contact with infected cats, disinfection of contaminated surfaces (FCV requires bleach-based disinfectants), and isolation of affected individuals. In multi-cat environments, vaccination, ventilation, stress reduction, and prompt isolation of symptomatic cats are essential [1, 2].

Conclusion

Feline respiratory infections are multifactorial diseases caused by a diverse array of viral, bacterial, fungal, and parasitic agents. While most infections resolve with supportive care, severe cases can be life-threatening, particularly in kittens and immunocompromised animals. The zoonotic risk is low for most agents but must be considered for B. bronchiseptica, C. felis, Mycobacterium species, and highly pathogenic avian influenza. Advances in molecular diagnostics, including portable LAMP platforms, have improved point-of-care detection. Therapeutic options continue to expand with novel antivirals, mRNA vaccines, and evidence-based antibiotic stewardship. A comprehensive approach integrating vaccination, biosecurity, diagnostic workup, and targeted therapy remains the standard of care.

References

[1] de Oliveira Santana W, Maciel JG, Flores RS, et al. Epidemiology and co-infection of URTD pathogens in domestic cats during COVID-19. Braz J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41405820/

[2] Slaviero M, de Almeida BA, de Castro LT, et al. Feline herpesvirus and calicivirus: Occurrence and pathology in cats with respiratory disease. Top Companion Anim Med. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41015115/

[3] Szymańska-Czerwińska M, Zaręba-Marchewka K, Woś M, et al. Prevalence, risk factors and genetic diversity of Chlamydia felis in cats. J Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41497455/

[4] Longobardi C, Pagnini U, Shin HJ, et al. Involvement of lipid raft during feline herpesvirus (FHV-1) infection on permissive cells: A potential target for antiviral treatment. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034370/

[5] Xu C, Zhao J, Liu H, et al. Construction of Reverse Genetics System for Feline Calicivirus FCV-BJ616 and Proteomic Analysis. Microbiologyopen. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603492/

[6] Magliocca M, Mandrioli L, Battilani M, et al. Description of a Virulent Systemic Feline Calicivirus Infection in a Kitten with Footpads Oedema and Fatal Pneumonia. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41305419/

[7] Doğan F, Acar G, Fedai T, et al. Investigation of the presence of gammaherpesvirus infections in cats with and without upper respiratory tract disease. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42035571/

[8] Vasinioti VI, Salvaggiulo A, Pellegrini F, et al. Feline Circovirus-1 in domestic cats: A multicentric European epidemiological study. Res Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41046711/

[9] Zahro AN, Poonsin P, Kasantikul T, et al. Molecular characterization and clinical insights into feline chaphamaparvovirus (FeChPV) in cats from Thailand. Infect Genet Evol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41033566/

[10] Dressler A, Wagner-Wiening C, Tegtmeyer B, et al. Highly pathogenic avian influenza A(H5N1) in poultry and domestic cats and occupational exposure among veterinary and other first responders, Germany, February 2026. Euro Surveill. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42141860/

[11] Jańczak D, Golke A, Szymański K, et al. Clinical and Laboratory Findings in Cats with Confirmed Avian Influenza A/H5N1 Virus Infection During the 2023 Outbreak in Poland: A Retrospective Case Series of 22 Cats. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41754452/

[12] Adaszek Ł, Domańska-Blicharz K, Jańczak D, et al. Cats infected with H5N1 avian influenza - a new infectious disease in Poland. Pol J Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41416603/

[13] Lee K, Song D, Lyoo KS. Mammalian adaptation and zoonotic risk of influenza A viruses in companion animals. J Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41332000/

[14] Li Y, Dong X, Yang A, et al. Development and efficacy evaluation of an inactivated Bordetella bronchiseptica vaccine in cats. Vaccine. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42217448/

[15] Ye Z, Wang C, Yan Q, et al. Epidemiology, Phylogenetic Divergence, and Differential Pathogenicity of Feline Respiratory Mycoplasma in China. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253332/

[16] Framst I, Beeton ML, Peterson SW, et al. Antimicrobial susceptibility and genomic determinants of resistance and virulence in Mycoplasma cynos and Mycoplasma felis. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41274178/

[17] Al-Galebi AAS, Al-Hassani MKA, Kadhim HM, et al. Phenotypic and molecular phylogeny of Klebsiella pneumoniae isolated from respiratory-diseased pet cats in Iraq. J Adv Vet Anim Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41069728/

[18] Bai Y, Zhao J, Wang Z, et al. A case of Rickettsia felis caused pneumonia and diagnosed by clinical analysis and Targeted Next-Generation Sequencing (tNGS) using Bronchoalveolar Lavage Fluid (BALF): A case report and literature review. J Infect Public Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41935438/

[19] Foster A, Kerr M, Gu J. Sinonasal Nocardia farcinica in a cat with comorbidities. Can Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41929723/

[20] Borrás P, Piras I, Dominguez L, et al. Feline tuberculosis due to Mycobacterium bovis: case series with clinical course, genotyping and therapeutic outcomes from Buenos Aires, Argentina. JFMS Open Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41884498/

[21] Mitra N, Jadhao A, Dhende AV, et al. First report of fatal feline pulmonary tuberculosis caused by the emerging zoonotic pathogen Mycobacterium orygis in a cat from India. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41712109/

[22] Dzimira S. Feline Cryptococcosis: Two Case Reports and a Literature Review. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41901732/

[23] Jańczak D, Moroz-Fik A, Radziejewska K, et al. Prevalence of Pulmonary Nematodes in Cats and Lung Ultrasound Findings in Separate Animal Cohorts: A Coprological, Molecular and Clinical Study. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41751082/

[24] Barros LA, Morelli S, Di Cesare A, et al. Investigation of Respiratory Metastrongyloids and Other Endoparasites in Domestic Cats Living in the States of Rio de Janeiro and Rio Grande do Sul, Brazil. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41594523/

[25] Swanstein HKJ, Müller AV, Willesen JL. Monitoring a severe Aelurostrongylus abstrusus infection in a kitten with point-of-care ultrasound and radiography. J Small Anim Pract. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41104485/

[26] Zhang MD, Xie ZF, Li XH, et al. Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in Cats. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41658352/

[27] Liu Z, Wu G, Mao J, et al. Lapachol, a dihydroorotate dehydrogenase inhibitor, demonstrates antiviral activity against feline calicivirus in vitro and in vivo. Antiviral Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41577199/

[28] Charnock L, Vernau K, Burkitt-Creedon J, et al. Clinical Management of Ophthalmic Manifestations of Upper Respiratory Tract Infections in Kittens. Vet Clin North Am Small Anim Pract. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41484008/

[29] Emdin F, Emdin A, Ong SWX, et al. Shorter versus longer durations of antibiotic treatment for pneumonia in dogs and cats: a systematic review and meta-analysis. J Am Vet Med Assoc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41547037/

[30] Gareis H, Schulz B. Evaluation of amyloid A and haptoglobin in the serum of cats with respiratory diseases. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42109870/

[31] Bi W, Wen F, Cai S, et al. An automated portable LAMP-based centrifugal microfluidic system for nucleic acid detection of multiple pathogens in feline upper respiratory disease. Mikrochim Acta. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40993306/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[32] Shao P, Lian Y, Liu X, et al. Rapid and sensitive detection of feline herpesvirus-1 using fluorescent microspheres as labels for immunochromatographic test strips. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41779066/

[33] Kaur J, Giannino D, Taylor R, et al. Nodular pyogranulomatous pneumonia associated with Besnoitia darlingi infection in a cat. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41782300/

[34] Kwan E, Legione AR, Hartley CA, et al. Transcriptomic analysis of Crandell-Rees feline kidney cell infections with field and vaccine feline calicivirus strains. Virus Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41435987/

[35] Faraji K, Hadi P, Seyedeh Parastoo Y, et al. Assessment of Oxidative Stress Biomarkers in Felines Infected with Calicivirus. Arch Razi Inst. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41179633/